Table 2 Patient Characteristics (n=50)
| Â | Non-CSS(n=35) | CSS(n=15) | P value |
|---|---|---|---|
Sex | Â | Â | 0.99 |
Male | 12(34.3%) | 5(33.3%) | Â |
Female | 23(65.7%) | 10(66.7%) | Â |
Age(years ±SD) | 56.2 ±15.1 | 48.6 ±14.8 | 0.11 |
Habit | Â | Â | Â |
Smoking | 3(8.6%) | 6(40.0%) | 0.02 |
Drinking | 8(22.9%) | 4(26.7%) | 0.99 |
Education(year) | 13.1 ±2.6 | 14.2 ±2.7 | 0.16 |
Married | 26(74.3%) | 8(53.3%) | 0.19 |
Disease duration(month) | 11.0 [5.0-24.0] | 11.0 [6.0-22.0] | 0.96 |
Treatment duration(month) | 9.0 [4.0-30.0] | 9.0 [5.5-24.5] | 0.92 |
Medical therapy | Â | Â | Â |
Antidepressant | 17(48.6%) | 6(40.0%) | 0.95 |
Benzodiazepines | 15(42.9%) | 9(60.0%) | 0.42 |
Questionnaire(cut-off) | Â | Â | Â |
DHI(\(\geqq \)46) | 9(25.7%) | 9(60.0%) | 0.04 |
HADS Anxiety(\(\geqq \)8) | 5(14.3%) | 12(80.0%) | <0.001 |
HADS Depression(\(\geqq \)8) | 9(25.7%) | 11(73.3%) | 0.004 |
PSQI(\(\geqq \)6) | 20(57.1%) | 12(80.0%) | 0.22 |